✦ LIBER ✦

Potent and Orally Bioavailable GPR142 Agonists as Novel Insulin Secretagogues for the Treatment of Type 2 Diabetes

✍ Scribed by Toda, Narihiro; Hao, Xiaolin; Ogawa, Yasuyuki; Oda, Kozo; Yu, Ming; Fu, Zice; Chen, Yi; Kim, Yongjae; Lizarzaburu, Mike; Lively, Sarah; Lawlis, Shauna; Murakoshi, Michiko; Nara, Futoshi; Watanabe, Nobuaki; Reagan, Jeff D.; Tian, Hui; Fu, Angela; Motani, Alykhan; Liu, Qingxiang; Lin, Yi-Jyun; Zhuang, Run; Xiong, Yumei; Fan, Peter; Medina, Julio; Li, Leping; Izumi, Masanori; Okuyama, Ryo; Shibuya, Satoshi

Book ID: 120460003
Publisher: American Chemical Society
Year: 2013
Tongue: English
Weight: 624 KB
Volume: 4
Category: Article
ISSN: 1948-5875
DOI: 10.1021/ml400186z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery of Phenylpropanoic Acid Deriva

Discovery of Phenylpropanoic Acid Derivatives Containing Polar Functionalities as Potent and Orally Bioavailable G Protein-Coupled Receptor 40 Agonists for the Treatment of Type 2 Diabetes

✍ Mikami, Satoshi; Kitamura, Shuji; Negoro, Nobuyuki; Sasaki, Shinobu; Suzuki, Mas 📂 Article 📅 2012 🏛 American Chemical Society 🌐 English ⚖ 689 KB

ChemInform Abstract: Discovery of a Nort

ChemInform Abstract: Discovery of a Nortropanol Derivative as a Potent and Orally Active GPR119 Agonist for Type 2 Diabetes.

✍ Tim Kowalski; et al. et al. 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 21 KB

AS1907417, a novel GPR119 agonist, as an

AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes

✍ Shigeru Yoshida; Hirotsugu Tanaka; Hiroyuki Oshima; Takao Yamazaki; Yasuhiro Yon 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 753 KB

Corrigendum to “Phenylalanine derivative

Corrigendum to “Phenylalanine derivatives as GPR142 agonists for the treatment of Type II diabetes” [Bioorg. Med. Chem. Lett. 22 (2012) 6218–6223]

✍ Du, Xiaohui; Kim, Yong-Jae; Lai, SuJen; Chen, Xi; Lizarzaburu, Mike; Turcotte, S 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Recent developments in the discovery of

Recent developments in the discovery of FFA1 receptor agonists as novel oral treatment for type 2 diabetes mellitus

✍ Defossa, Elisabeth; Wagner, Michael 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 860 KB

Discovery of Potent and Specific Fructos

Discovery of Potent and Specific Fructose-1,6-Bisphosphatase Inhibitors and a Series of Orally-Bioavailable Phosphoramidase-Sensitive Prodrugs for the Treatment of Type 2 Diabetes

✍ Dang, Qun; Kasibhatla, Srinivas Rao; Reddy, K. Raja; Jiang, Tao; Reddy, M. Rami; 📂 Article 📅 2007 🏛 American Chemical Society 🌐 English ⚖ 398 KB